Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IBI SA (Industrie Biomediche Insubri) is a Swiss biomedical company specializing in research, development, and production of innovative medical devices for tissue engineering and regenerative medicine. Their flagship product, SmartBone®, is a CE-marked class III medical device used for bone regeneration. The company's focus includes developing substitutes, grafts, 3D matrices, and scaffolds to support advanced clinical needs in orthopedics and related fields. They are ISO13485 certified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ibi Medical.